<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>REDUCTION OF DIALYZER FIBRIN DEPOSITION WITH SULPHINPYRAZONE</dc:title>
  <dc:creator>WOOD HF</dc:creator>
  <dc:creator>ASH G</dc:creator>
  <dc:creator>PARSONS V</dc:creator>
  <dc:creator>WESTON MJ</dc:creator>
  <dc:date>1979</dc:date>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:format>CLIN. NEPHROL.; DEU; DA. 1979; VOL. 12; NO 3; PP. 122-126; BIBL. 27 REF.</dc:format>
  <dc:subject xml:lang="fr">HEMODIALYSE PERIODIQUE</dc:subject>
  <dc:subject xml:lang="fr">HEMODIALYSEUR</dc:subject>
  <dc:subject xml:lang="fr">THROMBOSE</dc:subject>
  <dc:subject xml:lang="fr">FIBRINOGENE</dc:subject>
  <dc:subject xml:lang="fr">TAUX</dc:subject>
  <dc:subject xml:lang="fr">SANG</dc:subject>
  <dc:subject xml:lang="fr">CHIMIOTHERAPIE</dc:subject>
  <dc:subject xml:lang="fr">FIBRINE</dc:subject>
  <dc:subject xml:lang="fr">PREVENTION</dc:subject>
  <dc:subject xml:lang="fr">EPURATION EXTRARENALE</dc:subject>
  <dc:subject xml:lang="fr">COMPLICATION</dc:subject>
  <dc:subject xml:lang="fr">FACTEUR COAGULATION</dc:subject>
  <dc:subject xml:lang="fr">APPAREIL</dc:subject>
  <dc:subject xml:lang="fr">TRAITEMENT</dc:subject>
  <dc:subject xml:lang="fr">VAISSEAU SANGUIN PATHOLOGIE</dc:subject>
  <dc:subject xml:lang="fr">HOMME</dc:subject>
  <dc:subject xml:lang="fr">SULFINPYRAZONE</dc:subject>
  <dc:subject xml:lang="fr">REANIMATION</dc:subject>
  <dc:subject xml:lang="fr">PATHOLOGIE CARDIOVASCULAIRE</dc:subject>
  <dc:subject xml:lang="fr">CARDIOLOGIE</dc:subject>
  <dc:subject xml:lang="fr">PHARMACOLOGIE</dc:subject>
  <dc:subject xml:lang="en">MAINTENANCE HEMODIALYSIS</dc:subject>
  <dc:subject xml:lang="en">HEMODIALYZER</dc:subject>
  <dc:subject xml:lang="en">THROMBOSIS</dc:subject>
  <dc:subject xml:lang="en">FIBRINOGEN</dc:subject>
  <dc:subject xml:lang="en">BLOOD</dc:subject>
  <dc:subject xml:lang="en">CHEMOTHERAPY</dc:subject>
  <dc:subject xml:lang="en">FIBRIN</dc:subject>
  <dc:subject xml:lang="en">PREVENTION</dc:subject>
  <dc:subject xml:lang="en">EXTRARENAL DIALYSIS</dc:subject>
  <dc:subject xml:lang="en">COMPLICATION</dc:subject>
  <dc:subject xml:lang="en">COAGULATION FACTOR</dc:subject>
  <dc:subject xml:lang="en">TREATMENT</dc:subject>
  <dc:subject xml:lang="en">VASCULAR DISEASE</dc:subject>
  <dc:subject xml:lang="en">HUMAN</dc:subject>
  <dc:subject xml:lang="en">INTENSIVE CARE MEDICINE</dc:subject>
  <dc:subject xml:lang="en">CARDIOLOGY</dc:subject>
  <dc:subject xml:lang="en">PHARMACOLOGY</dc:subject>
  <dc:subject>002B02: Pharmacologie. Traitements medicamenteux / Pharmacology. Drug treatments</dc:subject>
  <dc:subject>002B27: Anesthesie. Reanimation. Transfusion. Therapie cellulaire et therapie genique / Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number PASCAL8050061508</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>